United States (US) CAR-T Cell Therapy Treatment Market (2025-2031) | Competitive Landscape, Share, Value, Size & Revenue, Analysis, Forecast, Industry, Companies, Outlook, Trends, Growth, Segmentation

Name: United States (US) CAR-T Cell Therapy Treatment Market (2025-2031) | Competitive Landscape & Share
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By Product (Autologous CAR-T Cells, Allogeneic CAR-T Cells), By Structure (First Generation CAR-T Cells, Second Generation Car-T Cells, Third Generation CAR-T Cells, Fourth Generation CAR-T Cells), By Targeted Antigens (Antigens on Solid Tumors, Antigens on Hematologic Malignancies), By Brand (Yescarta, Kymriah, Tecartus), By Therapeutic Application (Hematological Malignancies, Pancreatic Cancer, Breast Cancer, Lung Cancer, Gastric Cancer, Multiple Myeloma) And Competitive Landscape

Product Code: ETC9961481	Publication Date: Sep 2024	Updated Date: Aug 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Sumit Sagar	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

Key Highlights of the Report:

United States (US) CAR-T Cell Therapy Treatment Market Outlook
Market Size of United States (US) CAR-T Cell Therapy Treatment Market, 2024
Forecast of United States (US) CAR-T Cell Therapy Treatment Market, 2031
Historical Data and Forecast of United States (US) CAR-T Cell Therapy Treatment Revenues & Volume for the Period 2021- 2031
United States (US) CAR-T Cell Therapy Treatment Market Trend Evolution
United States (US) CAR-T Cell Therapy Treatment Market Drivers and Challenges
United States (US) CAR-T Cell Therapy Treatment Price Trends
United States (US) CAR-T Cell Therapy Treatment Porter's Five Forces
United States (US) CAR-T Cell Therapy Treatment Industry Life Cycle
Historical Data and Forecast of United States (US) CAR-T Cell Therapy Treatment Market Revenues & Volume By Product for the Period 2021- 2031
Historical Data and Forecast of United States (US) CAR-T Cell Therapy Treatment Market Revenues & Volume By Autologous CAR-T Cells for the Period 2021- 2031
Historical Data and Forecast of United States (US) CAR-T Cell Therapy Treatment Market Revenues & Volume By Allogeneic CAR-T Cells for the Period 2021- 2031
Historical Data and Forecast of United States (US) CAR-T Cell Therapy Treatment Market Revenues & Volume By Structure for the Period 2021- 2031
Historical Data and Forecast of United States (US) CAR-T Cell Therapy Treatment Market Revenues & Volume By First Generation CAR-T Cells for the Period 2021- 2031
Historical Data and Forecast of United States (US) CAR-T Cell Therapy Treatment Market Revenues & Volume By Second Generation Car-T Cells for the Period 2021- 2031
Historical Data and Forecast of United States (US) CAR-T Cell Therapy Treatment Market Revenues & Volume By Third Generation CAR-T Cells for the Period 2021- 2031
Historical Data and Forecast of United States (US) CAR-T Cell Therapy Treatment Market Revenues & Volume By Fourth Generation CAR-T Cells for the Period 2021- 2031
Historical Data and Forecast of United States (US) CAR-T Cell Therapy Treatment Market Revenues & Volume By Targeted Antigens for the Period 2021- 2031
Historical Data and Forecast of United States (US) CAR-T Cell Therapy Treatment Market Revenues & Volume By Antigens on Solid Tumors for the Period 2021- 2031
Historical Data and Forecast of United States (US) CAR-T Cell Therapy Treatment Market Revenues & Volume By Antigens on Hematologic Malignancies for the Period 2021- 2031
Historical Data and Forecast of United States (US) CAR-T Cell Therapy Treatment Market Revenues & Volume By Brand for the Period 2021- 2031
Historical Data and Forecast of United States (US) CAR-T Cell Therapy Treatment Market Revenues & Volume By Yescarta for the Period 2021- 2031
Historical Data and Forecast of United States (US) CAR-T Cell Therapy Treatment Market Revenues & Volume By Kymriah for the Period 2021- 2031
Historical Data and Forecast of United States (US) CAR-T Cell Therapy Treatment Market Revenues & Volume By Tecartus for the Period 2021- 2031
Historical Data and Forecast of United States (US) CAR-T Cell Therapy Treatment Market Revenues & Volume By Therapeutic Application for the Period 2021- 2031
Historical Data and Forecast of United States (US) CAR-T Cell Therapy Treatment Market Revenues & Volume By Hematological Malignancies for the Period 2021- 2031
Historical Data and Forecast of United States (US) CAR-T Cell Therapy Treatment Market Revenues & Volume By Pancreatic Cancer for the Period 2021- 2031
Historical Data and Forecast of United States (US) CAR-T Cell Therapy Treatment Market Revenues & Volume By Breast Cancer for the Period 2021- 2031
Historical Data and Forecast of United States (US) CAR-T Cell Therapy Treatment Market Revenues & Volume By Lung Cancer for the Period 2021- 2031
Historical Data and Forecast of United States (US) CAR-T Cell Therapy Treatment Market Revenues & Volume By Gastric Cancer for the Period 2021- 2031
Historical Data and Forecast of United States (US) CAR-T Cell Therapy Treatment Market Revenues & Volume By Multiple Myeloma for the Period 2021- 2031
United States (US) CAR-T Cell Therapy Treatment Import Export Trade Statistics
Market Opportunity Assessment By Product
Market Opportunity Assessment By Structure
Market Opportunity Assessment By Targeted Antigens
Market Opportunity Assessment By Brand
Market Opportunity Assessment By Therapeutic Application
United States (US) CAR-T Cell Therapy Treatment Top Companies Market Share
United States (US) CAR-T Cell Therapy Treatment Competitive Benchmarking By Technical and Operational Parameters
United States (US) CAR-T Cell Therapy Treatment Company Profiles
United States (US) CAR-T Cell Therapy Treatment Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) CAR-T Cell Therapy Treatment Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) CAR-T Cell Therapy Treatment Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) CAR-T Cell Therapy Treatment Market - Industry Life Cycle

3.4 United States (US) CAR-T Cell Therapy Treatment Market - Porter's Five Forces

3.5 United States (US) CAR-T Cell Therapy Treatment Market Revenues & Volume Share, By Product, 2021 & 2031F

3.6 United States (US) CAR-T Cell Therapy Treatment Market Revenues & Volume Share, By Structure, 2021 & 2031F

3.7 United States (US) CAR-T Cell Therapy Treatment Market Revenues & Volume Share, By Targeted Antigens, 2021 & 2031F

3.8 United States (US) CAR-T Cell Therapy Treatment Market Revenues & Volume Share, By Brand, 2021 & 2031F

3.9 United States (US) CAR-T Cell Therapy Treatment Market Revenues & Volume Share, By Therapeutic Application, 2021 & 2031F

4 United States (US) CAR-T Cell Therapy Treatment Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of cancer in the United States

4.2.2 Growing adoption of personalized medicine

4.2.3 Advancements in biotechnology and immunotherapy research

4.3 Market Restraints

4.3.1 High cost associated with CAR-T cell therapy treatment

4.3.2 Limited reimbursement policies for CAR-T cell therapy

4.3.3 Potential side effects and safety concerns

5 United States (US) CAR-T Cell Therapy Treatment Market Trends

6 United States (US) CAR-T Cell Therapy Treatment Market, By Types

6.1 United States (US) CAR-T Cell Therapy Treatment Market, By Product

6.1.1 Overview and Analysis

6.1.2 United States (US) CAR-T Cell Therapy Treatment Market Revenues & Volume, By Product, 2021- 2031F

6.1.3 United States (US) CAR-T Cell Therapy Treatment Market Revenues & Volume, By Autologous CAR-T Cells, 2021- 2031F

6.1.4 United States (US) CAR-T Cell Therapy Treatment Market Revenues & Volume, By Allogeneic CAR-T Cells, 2021- 2031F

6.2 United States (US) CAR-T Cell Therapy Treatment Market, By Structure

6.2.1 Overview and Analysis

6.2.2 United States (US) CAR-T Cell Therapy Treatment Market Revenues & Volume, By First Generation CAR-T Cells, 2021- 2031F

6.2.3 United States (US) CAR-T Cell Therapy Treatment Market Revenues & Volume, By Second Generation Car-T Cells, 2021- 2031F

6.2.4 United States (US) CAR-T Cell Therapy Treatment Market Revenues & Volume, By Third Generation CAR-T Cells, 2021- 2031F

6.2.5 United States (US) CAR-T Cell Therapy Treatment Market Revenues & Volume, By Fourth Generation CAR-T Cells, 2021- 2031F

6.3 United States (US) CAR-T Cell Therapy Treatment Market, By Targeted Antigens

6.3.1 Overview and Analysis

6.3.2 United States (US) CAR-T Cell Therapy Treatment Market Revenues & Volume, By Antigens on Solid Tumors, 2021- 2031F

6.3.3 United States (US) CAR-T Cell Therapy Treatment Market Revenues & Volume, By Antigens on Hematologic Malignancies, 2021- 2031F

6.4 United States (US) CAR-T Cell Therapy Treatment Market, By Brand

6.4.1 Overview and Analysis

6.4.2 United States (US) CAR-T Cell Therapy Treatment Market Revenues & Volume, By Yescarta, 2021- 2031F

6.4.3 United States (US) CAR-T Cell Therapy Treatment Market Revenues & Volume, By Kymriah, 2021- 2031F

6.4.4 United States (US) CAR-T Cell Therapy Treatment Market Revenues & Volume, By Tecartus, 2021- 2031F

6.5 United States (US) CAR-T Cell Therapy Treatment Market, By Therapeutic Application

6.5.1 Overview and Analysis

6.5.2 United States (US) CAR-T Cell Therapy Treatment Market Revenues & Volume, By Hematological Malignancies, 2021- 2031F

6.5.3 United States (US) CAR-T Cell Therapy Treatment Market Revenues & Volume, By Pancreatic Cancer, 2021- 2031F

6.5.4 United States (US) CAR-T Cell Therapy Treatment Market Revenues & Volume, By Breast Cancer, 2021- 2031F

6.5.5 United States (US) CAR-T Cell Therapy Treatment Market Revenues & Volume, By Lung Cancer, 2021- 2031F

6.5.6 United States (US) CAR-T Cell Therapy Treatment Market Revenues & Volume, By Gastric Cancer, 2021- 2031F

6.5.7 United States (US) CAR-T Cell Therapy Treatment Market Revenues & Volume, By Multiple Myeloma, 2021- 2031F

7 United States (US) CAR-T Cell Therapy Treatment Market Import-Export Trade Statistics

7.1 United States (US) CAR-T Cell Therapy Treatment Market Export to Major Countries

7.2 United States (US) CAR-T Cell Therapy Treatment Market Imports from Major Countries

8 United States (US) CAR-T Cell Therapy Treatment Market Key Performance Indicators

8.1 Patient response rate to CAR-T cell therapy

8.2 Number of clinical trials and research studies in the field

8.3 Adoption rate of CAR-T cell therapy by healthcare providers

9 United States (US) CAR-T Cell Therapy Treatment Market - Opportunity Assessment

9.1 United States (US) CAR-T Cell Therapy Treatment Market Opportunity Assessment, By Product, 2021 & 2031F

9.2 United States (US) CAR-T Cell Therapy Treatment Market Opportunity Assessment, By Structure, 2021 & 2031F

9.3 United States (US) CAR-T Cell Therapy Treatment Market Opportunity Assessment, By Targeted Antigens, 2021 & 2031F

9.4 United States (US) CAR-T Cell Therapy Treatment Market Opportunity Assessment, By Brand, 2021 & 2031F

9.5 United States (US) CAR-T Cell Therapy Treatment Market Opportunity Assessment, By Therapeutic Application, 2021 & 2031F

10 United States (US) CAR-T Cell Therapy Treatment Market - Competitive Landscape

10.1 United States (US) CAR-T Cell Therapy Treatment Market Revenue Share, By Companies, 2024

10.2 United States (US) CAR-T Cell Therapy Treatment Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Africa CAR-T Cell Therapy Treatment Market

Ecuador CAR-T Cell Therapy Treatment Market

El Salvador CAR-T Cell Therapy Treatment Market

Equatorial Guinea CAR-T Cell Therapy Treatment Market

Eritrea CAR-T Cell Therapy Treatment Market

Estonia CAR-T Cell Therapy Treatment Market

Global CAR-T Cell Therapy Treatment Market

Middle East CAR-T Cell Therapy Treatment Market

North America CAR-T Cell Therapy Treatment Market

Global Go To Market Strategy - 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here